Article
Development of pyrosequencing methods for the rapid detection of RAS mutations in clinical samples.
Experimental and molecular pathology - 1 Oct 2015
Cortes Ulrich, Guilloteau Karline, Rouvreau Mélanie, Archaimbault Céline, Villalva Claire, Karayan-Tapon Lucie
Abstract excerpt
In advanced colorectal carcinoma (CRC) patients, extended RAS mutations testing (KRAS exons 2 to 4 and NRAS exons 2 to 4) is a prerequisite for patient stratification to anti-EGFr therapy. Accurately distinguishing mutant patients from potential responders has a clinically critical impact, and thus effective and low cost methods are needed for identification of the mutation status. We have developed quantitative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
